BHC
Price
$6.45
Change
-$0.01 (-0.15%)
Updated
Sep 26, 02:35 PM (EDT)
Capitalization
2.41B
34 days until earnings call
TKPHF
Price
$29.31
Change
+$1.11 (+3.94%)
Updated
Sep 24 closing price
Capitalization
47.5B
Interact to see
Advertisement

BHC vs TKPHF

Header iconBHC vs TKPHF Comparison
Open Charts BHC vs TKPHFBanner chart's image
Bausch Health Companies
Price$6.45
Change-$0.01 (-0.15%)
Volume$10K
Capitalization2.41B
Takeda Pharmaceutical
Price$29.31
Change+$1.11 (+3.94%)
Volume$66.39K
Capitalization47.5B
BHC vs TKPHF Comparison Chart in %
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. TKPHF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Buy and TKPHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BHC: $6.46 vs. TKPHF: $29.31)
Brand notoriety: BHC: Notable vs. TKPHF: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BHC: 73% vs. TKPHF: 95%
Market capitalization -- BHC: $2.41B vs. TKPHF: $47.5B
BHC [@Pharmaceuticals: Generic] is valued at $2.41B. TKPHF’s [@Pharmaceuticals: Generic] market capitalization is $47.5B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 0 FA rating(s) are green whileTKPHF’s FA Score has 2 green FA rating(s).

  • BHC’s FA Score: 0 green, 5 red.
  • TKPHF’s FA Score: 2 green, 3 red.
According to our system of comparison, both BHC and TKPHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 4 TA indicator(s) are bullish while TKPHF’s TA Score has 5 bullish TA indicator(s).

  • BHC’s TA Score: 4 bullish, 6 bearish.
  • TKPHF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TKPHF is a better buy in the short-term than BHC.

Price Growth

BHC (@Pharmaceuticals: Generic) experienced а -6.24% price change this week, while TKPHF (@Pharmaceuticals: Generic) price change was +3.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.69%. For the same industry, the average monthly price growth was +25.25%, and the average quarterly price growth was +68.51%.

Reported Earning Dates

BHC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.69% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.5B) has a higher market cap than BHC($2.41B). TKPHF has higher P/E ratio than BHC: TKPHF (50.60) vs BHC (24.85). TKPHF YTD gains are higher at: 9.570 vs. BHC (-19.851). TKPHF has higher annual earnings (EBITDA): 1.13T vs. BHC (3B). TKPHF has more cash in the bank: 419B vs. BHC (1.73B). BHC has less debt than TKPHF: BHC (21.7B) vs TKPHF (4.51T). TKPHF has higher revenues than BHC: TKPHF (4.48T) vs BHC (9.86B).
BHCTKPHFBHC / TKPHF
Capitalization2.41B47.5B5%
EBITDA3B1.13T0%
Gain YTD-19.8519.570-207%
P/E Ratio24.8550.6049%
Revenue9.86B4.48T0%
Total Cash1.73B419B0%
Total Debt21.7B4.51T0%
FUNDAMENTALS RATINGS
BHC vs TKPHF: Fundamental Ratings
BHC
TKPHF
OUTLOOK RATING
1..100
7230
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10089
PRICE GROWTH RATING
1..100
6260
P/E GROWTH RATING
1..100
3728
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (5) in the null industry is in the same range as BHC (35) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's SMR Rating (89) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's Price Growth Rating (60) in the null industry is in the same range as BHC (62) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's P/E Growth Rating (28) in the null industry is in the same range as BHC (37) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCTKPHF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
47%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
43%
Advances
ODDS (%)
Bullish Trend 9 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
52%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAIGX23.01N/A
N/A
T. Rowe Price International Value Eq Adv
FSHOX128.54N/A
N/A
Fidelity Select Construction & Housing
OGICX39.93N/A
N/A
Invesco Global Opportunities C
AIAGX10.81N/A
N/A
abrdn Real Estate Fund A
TLOFX10.02N/A
N/A
Transamerica Large Value Opps R4

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TAK - TKPHF
27%
Poorly correlated
-2.07%
TEVJF - TKPHF
17%
Poorly correlated
+39.73%
ZTS - TKPHF
16%
Poorly correlated
-0.38%
BHC - TKPHF
15%
Poorly correlated
-2.86%
QNTM - TKPHF
13%
Poorly correlated
-0.35%
More